TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -4 | 1 | 14 | 37 | 121 | 118 | 48 |
| S | %wins | 67 | 67 | 67 | 0 | 33 | 0 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/24/14 14:55 | 11/14/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | H | Fmr Offi | S.dm | -10,357 | 8.84 | 4 | -1,172 | -40 | 1,765 | D | 310 | 37 | -43 | -34 | -12 | -21 | -29 | -9 | 5 | 22 | 54 | 74 | 265 | 145 |
10/9/14 11:11 | 10/1/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | S | -3 | 0.0100 | 6 | -300 | -9 | 2,995 | D | 62 | -49 | -4 | -22 | -11 | 7 | -4 | -5 | -5 | -4 | 34 | 121 | 83 | |
6/3/14 21:50 | 5/30/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | S | -4,427 | 15.14 | 6 | -292 | -9 | 2,867 | D | 113 | 106 | -19 | 4 | 18 | 13 | 4 | -12 | -15 | -7 | 2 | -22 | 127 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |